Knowledge Tree
Relations (1)
related 2.32 — strongly supporting 4 facts
Inflammation is a key driver of cardiovascular events, as evidenced by the role of atherosclerosis as a pro-inflammatory state [1] and the use of inflammatory markers like hs-CRP to predict cardiovascular risk [2]. Furthermore, therapeutic interventions like statins reduce cardiovascular events by targeting inflammatory biomediators [3], while external factors like smoking link inflammatory responses to future cardiac outcomes [4].
Facts (4)
Sources
Chronic Inflammation - StatPearls - NCBI Bookshelf ncbi.nlm.nih.gov 2 facts
claimStatins have anti-inflammatory effects by reducing multiple circulating and cellular biomediators of inflammation, which contributes to the reduction in cardiovascular events.
claimAtherosclerosis is a pro-inflammatory state characterized by chronic low-grade inflammation that increases the risk of cardiovascular events such as myocardial infarction and stroke.
Chronic Inflammation: How to Test For it and Prevent it medichecks.com 1 fact
referenceThe National Center for Biotechnology Information (NCBI) published 'Smoking and inflammation: the cause and consequences of inflammation' in the American Journal of Physiology in 2005, which notes that smoking triggers an immunologic response and that inflammatory markers predict future cardiovascular events.
Tracking Inflammation Through Biomarkers rupahealth.com 1 fact
claimElevated high-sensitivity C-reactive protein (hs-CRP) levels indicate inflammation associated with atherosclerosis and increased cardiovascular risk, which prompts early intervention to reduce the risk of future adverse cardiac events.